This article was originally published in The Tan Sheet
Procter & Gamble is extending its pain-relief wrap line with the launch of ThermaCare Knee Wrap, the firm's "first product designed specifically for the knee" and targeted to osteoarthritis sufferers. The air-activated heat wrap "delivers at least eight hours of continuous, low-level heat directly to the knee or other joints to relieve pain and reduce stiffness," according to P&G, and "provides long-lasting pain relief without the risk of drug interactions or upset stomach which can occur with the use of oral analgesics," says Wayne Riskin, MD, University of Miami School of Medicine. The product will be available in the pain relief sections of food, drug and mass retailers beginning in October...
You may also be interested in...
A trio of newly finalized guidance documents from the US agency dated 25 September explain how the Accreditation Scheme for Conformity Assessment pilot will work, and what biocompatibility and safety standards will apply.
Approval of Alaway Preservative Free (ketotifen fumarate, 0.035) comes 15 months after FDA submitted a complete response letter to Bausch and the active ingredient developer, Eton Pharmaceuticals.
Unfounded expectation some firms have for FDA to protect their investments in preparing successful NDI notifications is part of industry’s overall interest in increased regulation of the market, says Steven Tave, Office of Dietary Supplement Programs director.